- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02234258
Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis
May 17, 2022 updated by: Jean Addington, PhD, University of Calgary
Schizophrenia and other psychotic disorders are serious and debilitating mental illnesses that incur substantial suffering for patients and major challenges to the investigators health care and legal systems.
The prodrome is the period prior to onset of psychosis when functional decline and clinical symptoms gradually emerge.
The presence of a clinical high-risk (CHR) syndrome in young adults is associated with heightened risk (25-35%) for the later development of psychosis, and for those who do not necessarily go on to develop a psychotic illness, research has suggested that the majority continue to have fluctuating subthreshold symptoms and poor social and role functioning.
There are no specific treatments to help with these functional difficulties.
However, recent findings suggest that in people with schizophrenia, Cognitive Behavioral and Social Skills Training (CBSST) leads to significantly greater increase in the frequency of social functioning activities compared to treatment as usual or goal-focused supportive therapy, and preliminary data suggest CBSST is a feasible treatment for CHR.
This proposal is a competitive application for a three-site, longitudinal study aimed at testing the effectiveness and feasibility as well as mediators and mechanisms of action of a manualized CBSST intervention that will target functional difficulties associated with clinical risk states for psychosis.
The goals are 1) to examine whether CBSST compared to a placebo intervention (psychoeducation) matched for group involvement and therapist time improves functioning in youth at CHR and 2) to determine whether reduction in defeatist beliefs and improvement in social competence mediate change in psychosocial functioning in CHR youth in the CBSST.
In this single-blind randomized 2-arm trial participants will be randomized to one of two treatments: CBSST, an 18-week group comprised of three modules; 1) Cognitive Skills; 2) Social Skills; and 3) Problem Solving, or a psychoeducation support group that does not teach active cognitive behavioral therapy or social skills training.
Over a five-year period, the multi-site collaboration will follow large CHR sample that will undergo comprehensive assessments of psychosocial and behavioral changes, to examine changes in social and role functioning, as well as symptom changes from baseline to the end of treatment, and to 6 month follow-up.
This approach will demonstrate the feasibility of a treatment for which it is easy to train therapists and which can readily be disseminated to regular clinical community practice.
In addition, it will provide insights into likely approaches to halting or mitigating the pathological process and advance the investigators understanding of risk prediction; both critical steps in prevention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
203
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N4Z6
- Mathison Centre for Research and Education, University of Calgary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- have prodromal criteria in the past 4 years
- one attenuated psychotic symptom rated 3 or more
- rating on social functioning <6
Exclusion Criteria:
- meet criteria for a psychotic disorder neurological disorder IQ<70
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive behavioral social skills
In Cognitive behavioral social skills training (CBSST), skills-based CBT is used to teach individuals how to correct inaccurate dysfunctional thoughts that interfere with goal-directed activities, including defeatist expectancies, low self-efficacy beliefs, and anomalous beliefs.
SST focuses on behaviorally-based instruction of interpersonal social skills, utilizing role-modeling, rehearsal, corrective feedback, and positive reinforcement to facilitate learning.
In the modified version of CBSST used in this project: 1) we will strengthen the focus on corrective feedback from successful social interactions; 2) focus on normalization and destigmatization of attenuated psychotic symptoms; 3) add motivational interviewing techniques to promote treatment engagement; and 4) use examples and role plays.
CBSST will be delivered in three 6-session modules (i.e., Cognitive Skills, Social Skills, and Problem Solving Skills), a total of 18 90-minute group sessions.
|
|
|
Active Comparator: Psychoeducation
The purpose of this alternative treatment is to match CBSST for the nonspecific effects of therapist contact and interest, social interaction and support.
Common factors include client expectancy, providing a rationale for change, therapist factors and therapeutic alliance.
The psychoeducation group will meet weekly, for a total of 18 90-minute sessions.
Therapists will follow brief guidelines as to what they can and cannot do.
In each session the therapists will ask how the previous week had been.
Any crises will be dealt with, and advice will be offered to help with any immediate problems.
No active CBT or SST techniques will be taught or used.
Psychoeducational information about high risk for psychosis will be offered.
There will be a focus on listening, reflecting and empathizing, and demonstrating uncritical acceptance and genuineness.
Social exchanges amongst participants will be encouraged.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Global Social Functioning Scale
Time Frame: 6 and 12 months
|
This is a clinical rating scale that will be given to all participants at baseline, then 6 months which is the end of treatment and then 6 months after the end of treatment so approximately 12 months after baseline to determine if there is an improvement in social functioning
|
6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Defeatist Beliefs
Time Frame: 6 and 12 months
|
This is a clinical rating scale that will be administer at the end of treatment (6 months) and 6 months after the end of treatment (12 months).
This will be administered to all participants
|
6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jean M Addington, PhD, University of Calgary
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
August 1, 2021
Study Completion (Actual)
August 1, 2021
Study Registration Dates
First Submitted
September 3, 2014
First Submitted That Met QC Criteria
September 8, 2014
First Posted (Estimate)
September 9, 2014
Study Record Updates
Last Update Posted (Actual)
May 24, 2022
Last Update Submitted That Met QC Criteria
May 17, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH105178
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on At Risk of Psychosis
-
Pakistan Institute of Living and LearningRecruitingIndividuals at Risk of First Episode PsychosisPakistan
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Trial Unit, Center for Clinical Intervention Research; Center for...CompletedPatients at Ultra-high Risk of PsychosisDenmark
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
University of OxfordWellcome Trust; Jazz PharmaceuticalsNot yet recruitingClinical High Risk for Psychosis | Clinical High Risk for Psychosis (CHR) | Clinical High Risk for Developing PsychosisUnited Kingdom, Italy, Greece, Finland, Germany, Netherlands, Austria, Canada, Spain, Switzerland
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedFirst Episode Psychosis (FEP) | At Risk Mental State (ARMS)United States
-
Monument Therapeutics LimitedNational Institute of Mental Health (NIMH); Foundation for the National Institutes... and other collaboratorsRecruitingClinical High Risk for Psychosis (CHR)United States
-
University of California, DavisSacramento County Behavioral Health ServicesRecruitingClinical High Risk for Psychosis | Ultra High Risk for PsychosisUnited States
-
University of UdineNational Research Council (CNR), Institute of Biomolecular Chemistry (ICB)...RecruitingClinical High Risk for Psychosis | Ultra High Risk for Psychosis | Attenuated Psychotic SymptomsItaly
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingClinical High Risk Syndrome of PsychosisChina
-
Shanghai Mental Health CenterRecruitingClinical High-risk Syndrome of PsychosisChina
Clinical Trials on Psychoeducation
-
University of GaziantepCompletedPsychoeducation StudyTurkey (Türkiye)
-
The University of Texas Health Science Center,...TerminatedBipolar Disorder Family MembersUnited States
-
The Hong Kong Polytechnic UniversityHealth and Medical Research FundNot yet recruitingCaregiving Stress
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAlzheimer's Association; University of BergamoCompleted
-
ŞİRİN HARKİNEnrolling by invitationSchizophrenia | Well-being | Caregiver | Psychoeducation | Communication SkillsTurkey
-
University of Alabama at BirminghamCompletedChronic Low Back PainUnited States
-
Virginia Polytechnic Institute and State UniversityUniversity of Virginia; Autism Speaks; National Center for Advancing Translational...CompletedAutism Spectrum DisorderUnited States
-
Istanbul Medeniyet UniversityCompletedElderly People | Depressive Symptoms | DespondencyTurkey
-
University of Missouri, Kansas CityUniversity of KansasCompletedMultiple SclerosisUnited States
-
Uppsala UniversityCompleted